Cerebral Therapeutics
Manufacturing · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12635 E Montview Blvd, Aurora, Colorado,...Phone Number
(303) 547-3448Website
www.cerebraltherapeutics.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Cerebral Therapeutics
Cerebral Therapeutics, LLC (www.cerebraltherapeutics.com) is a privately-held company founded with the goal of addressing the well-recognized limitations of existing treatments for uncontrolled neurological diseases. Cerebral Therapeutics is combining advanced micro-dosing technology with proprietary medications to precisely deliver treatments to the other side of the blood-brain barrier to improve the lives of patients with uncontrolled neurological disease. With a promising route of administration, Cerebral Therapeutics offers a new approach to managing neurological diseases by means of delivering ideal dosing to targeted sites within the brain. Initially, Cerebral Therapeutics is focused on improving outcomes and propagation in the brain. Future cerebral therapeutic areas include obesity, Alzheimer's disease, Parkinson's disease, anxiety spectrum disorder, and brain cancer. FLOWONIX and PROMETRA are registered trademarks of Flowonix Medical, Inc.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cerebral Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cerebral Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cerebral Therapeutics
Check if Cerebral Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cerebral Therapeutics has new funding data
Cerebral Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cerebral Therapeutics is spiking on competitors!
Product Launch: Get notified when Cerebral Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Click to see if Cerebral Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Cerebral Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cerebral Therapeutics
Compare insights from companies similar to Cerebral Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cerebral Therapeutics
$6.7M
11-50
Private
$86M
2010
N/A
Company Profile Activity
Activity Insights
Cerebral Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cerebral Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cerebral Therapeutics.
Cerebral Therapeutics financials insights
Gather financial insights about Cerebral Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$11M
2020
Series B
$35M
2022
Series C
$40M
Cerebral Therapeutics Tech Stack
A closer look at the technologies used by Cerebral Therapeutics
Most Recent Scoops
New Hire
Executive Move
Lateral Move
Executive Move
Funding
New Hire
Executive Move
Funding
Funding
Cerebral Therapeutics News & Media
Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing
AURORA, Colo.--(BUSINESS WIRE)--Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today $40 million in Series C funding led by Lynx1 Capital Management with participation from existing investors RA Capital Management, Perceptive Advisors, Vivo Capital LLC, and Granite Point Capital Management L.P. In conjunction with the financing round, Weston Nichols, Ph.D., Managing Partner of Lynx1 Capital Management and Tim Scannell, foCerebral Therapeutics, Inc. Names Guy Anthony as Chief Financial Officer
AURORA, Colo.--(BUSINESS WIRE)--Cerebral Therapeutics, Inc. Names Guy Anthony as Chief Financial OfficerCerebral Therapeutics Announces Enrollment of First Patient in a Multicenter Randomized Controlled Phase 2b Trial in Epilepsy
AURORA, Colo.--(BUSINESS WIRE)--Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative treatments for neurological diseases, today announced that the first patient has been enrolled in a Phase 2b study of intracerebroventricular drug delivery of the anti-seizure medication CT-010 in patients with medically refractory epilepsy. The trial is enrolling adult epilepsy patients with temporal lobe onset, with or without secondary generalized seizures. A clinical feCerebral Therapeutics Appoints Stephen J. Farr as Chairman and Welcomes Stephen D. Collins to the Board of Directors
AURORA, Colo.--(BUSINESS WIRE)--Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative treatments for neurological diseases, has appointed Stephen J. Farr, PhD as Chairman of the board of directors. Dr. Farr is the Co-Founder, President, and Chief Executive Officer of Zogenix, a biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. “Dr
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerebral Therapeutics
Sign Up For FreeTo access detailed company insights
Cerebral Therapeutics, LLC (www.cerebraltherapeutics.com) is a privately-held company founded with the goal of addressing the well-recognized limitations of existing treatments for uncontrolled neurological diseases. Cerebral Therapeutics is combining advanced micro-dosing technology with proprietary medications to precisely deliver treatments to t... Read More
